CD274 and colon carcinoma: For instance, in mouse colon carcinoma models, in which a fractionated RT cycle of 2 Gy × 5 fractions was administered, Dovedi et al. evaluated three different schedules including the administration of anti-PD-L1 mAbs on day 1 of the RT cycle (schedule A), day 5 of the cycle (schedule B), or 7 days after the completion of RT (schedule C).